Caxton Associates (UK)’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$934K Buy
67,169
+42,672
+174% +$666K 0.02% 423
2026
Q1
$308K Buy
+24,497
New +$248K 0.01% 602
2025
Q4
Sell
-18,310
Closed -$172K 758
2025
Q3
$172K Sell
18,310
-42,444
-70% -$395K ﹤0.01% 649
2025
Q2
$545K Sell
60,754
-31,639
-34% -$252K 0.01% 404
2025
Q1
$806K Buy
+92,393
New +$930K 0.03% 370

Other funds holding ADTN

Caxton Associates (UK)'s ADTN Position: Q2 2026 in Review

Caxton Associates (UK) increased its Adtran (ADTN) stake by 174% in Q2 2026, buying an estimated $666K and bringing the position to 67,169 shares worth $934K. The position accounts for 0.02% of the portfolio, ranked #423.

Caxton Associates (UK) first reported a position in ADTN in Q1 2025 and has held it in 5 quarters since. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • Caxton Associates (UK) held 67,169 shares of Adtran worth $934K as of Q2 2026.
  • Caxton Associates (UK) bought 42,672 Adtran shares in Q2 2026, an estimated $666K.
  • Adtran made up 0.02% of Caxton Associates (UK)'s portfolio in Q2 2026, its #423 holding.
  • Caxton Associates (UK) first reported a position in Adtran in Q1 2025 and has held it in 5 quarters since.
  • 249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.